Revision of Outcome of Board Meeting held on 7th February,2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Symbiox Investment & Trading Co. Ltd announced the outcome of its board meeting held on 7th February 2026, where it approved the unaudited financial results for the quarter and nine months ended 31st December 2025. For Q3 FY26, revenue from operations stood at Rs. 8.60 lakh, down sharply from Rs. 77.56 lakh in the same quarter last year. Profit after tax for the quarter was Rs. 1.23 lakh versus Rs. 15.85 lakh in Q3 FY25. For the nine-month period, revenue fell to Rs. 151.86 lakh from Rs. 276.36 lakh, while PAT dropped to Rs. 14.01 lakh from Rs. 49.13 lakh. The statutory auditor (S S RV & Associates) issued an unqualified limited review report with no qualifications or modifications. The company operates in the investment and trading space and trades on BSE, CSE, and MSEI.
Sharp year-on-year decline in both revenue (~89% drop in Q3 and ~45% drop in 9M) and profitability signals significant business slowdown, which is negative for shareholders. The clean audit report provides some reassurance on accounting quality, but the weakening top-line and bottom-line could weigh on investor sentiment.